The ability of the panel to accurately predict a COL9 mutation was a result of the previously documented differences in the clinical and radiographic presentation of MED caused by a type IX collagen mutation compared to COMP and MATN3 mutations [Lachman et al., 2005; Unger et al., 2008, 2001]. This evidence concerns the gene MATN3 and multiple epiphyseal dysplasia.